Vasospasm, Intracranial: all 82 studies

Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageNot yet recruitingNCT07643922Not applicable
• Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid HemorrhageRecruitingNCT07614906
• Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid HemorrhageNot yet recruitingNCT07577739Not applicable
• Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced HypertensionRecruitingNCT07305922
• The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageRecruitingNCT07131696Not applicable
• Mechanisms of Brain-Heart Injury of Post-Intracranial HemorrhageRecruitingNCT06906432
• Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEntsRecruitingNCT06893588
• Mechanical Intracranial Artery DilAtation Using Stent-retriever for Cerebral VasospasmNot yet recruitingNCT06615882Not applicable
• Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University HospitalRecruitingNCT06560372Not applicable
• Early Warning of Delayed Cerebral IschemiaRecruitingNCT06006975
• Cervical Sympathetic Block in Patients With Cerebral VasospasmEnrolling by invitationNCT05230134Not applicable
• Stellate Ganglion Block and Cerebral VasospasmRecruitingNCT04691271Not applicable
• Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial AdministrationRecruitingNCT04649398
• Prevention of Vasospasm in SAH Through CSF TreatmentRecruitingNCT04490161Not applicable
• Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid HemorrhageRecruitingNCT03065231Not applicable
• Variability in Transcranial Doppler Technique in Neuro-Critical Care PatientsTerminatedNCT04583163Results posted
• Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)CompletedNCT03611790Not applicableResults posted
• Acetazolamide Challenge With Perfusion in the Prediction of Cerebral VasospasmCompletedNCT03377049Phase 4Results posted
• Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition TrialCompletedNCT03318783Phase 1/2Results posted
• Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid HemorrhageTerminatedNCT02712788Phase 2Results posted
• The Intra-arterial Vasospasm TrialTerminatedNCT01996436Phase 4Results posted
• Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm InterventionsTerminatedNCT01845441Phase 2Results posted
• Safety Study of Nicardipine to Treat Cerebral VasospasmTerminatedNCT01810302Phase 2Results posted
• Safety Study of Dantrolene in Subarachnoid HemorrhageCompletedNCT01024972Phase 1/2Results posted
• Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral VasospasmTerminatedNCT00585559Phase 3Results posted
• Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid HemorrhageTerminatedNCT00487461Not applicableResults posted
• Treatment of Subarachnoid Hemorrhage With Human AlbuminTerminatedNCT00283400Not applicableResults posted
• Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic DeficitActive, not recruitingNCT06881329
• The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSuspendedNCT06443177Not applicable
• Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.CompletedNCT06303349Not applicable
• Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)CompletedNCT05268445Not applicable
• Angiotensin Metabolite Profile After Subarachnoid HemorrhageStatus unknownNCT05222542
• Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim StudyTerminatedNCT05150002Not applicable
• Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.CompletedNCT05131295Phase 3
• Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)Active, not recruitingNCT04876638Phase 2
• Brain Aneurysms: Utility of Cisternal Urokinase IrrigationCompletedNCT04792944
• Therapeutic Hypercapnia After Aneurysmal Subarachnoid Hemorrhage - Optimum Duration of HypercapniaCompletedNCT04687605Not applicable
• Magnesium Treating Subarachnoid Hemorrhage VasospasmStatus unknownNCT04613960Phase 2/3
• Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid HemorrhageStatus unknownNCT04512859Not applicable
• "The Effect of Stellate Ganglion Block in Severe Brain Injury"CompletedNCT04208477Not applicable
• Prolonged Vasospasm in Subarachnoid HemorrhageCompletedNCT04193124
• Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)TerminatedNCT04148105Phase 4
• Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced VasospasmCompletedNCT03517670
• Lumenate Observational Vasospasm Interventional Trial (LOVIT)Status unknownNCT03511040Not applicable
• Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid HemorrhageCompletedNCT03214705
• Sildenafil for DCIStatus unknownNCT03028298Phase 1
• Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular DiseasesCompletedNCT02991157
• Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral VasospasmCompletedNCT02775318Phase 1
• An Evaluation of a Non-invasive Brain MonitorStatus unknownNCT02775136Not applicable
• An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral VasospasmStatus unknownNCT02704637Not applicable
• Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid HemorrhageCompletedNCT02560532Phase 2
• Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing HeparinSuspendedNCT02501434Phase 2
• Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:Status unknownNCT02432157Phase 1/2
• Cervical Spinal Cord Stimulation in Cerebral VasospasmWithdrawnNCT02426827Not applicable
• Identification of Novel Molecular Markers for VasospasmCompletedNCT02389634
• Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid HemorrhageCompletedNCT02350335Not applicable
• Acupuncture for Cerebral Vasospasm After Subarachnoid HemorrhageCompletedNCT02275949Not applicable
• Perioperative Neuroprotection of Stellate Ganglion BlockStatus unknownNCT02275247Not applicable
• Safety Study of Carotid Body Neurostimulation to Treat Cerebral VasospasmStatus unknownNCT02129413Not applicable
• CT Perfusion Imaging to Predict Vasospasm in Subarachnoid HemorrhageActive, not recruitingNCT02056769Not applicable
• Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)WithdrawnNCT02011321Phase 2
• Effect of Intraventricular tPA Following Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01878136Phase 1/2
• Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid HemorrhageCompletedNCT01799018
• Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing VasospasmCompletedNCT01595802
• Neuroinflammation and Bispectral Index After Subarachnoid HemorrhageStatus unknownNCT01516671
• The Tilburg Vasospasm StudyTerminatedNCT01407614Phase 2/3
• Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid HemorrhageStatus unknownNCT01400360Not applicable
• Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage SubjectsTerminatedNCT01343537Early Phase 1
• Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) PatientsStatus unknownNCT01292278
• EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAHCompletedNCT01258257Phase 3
• Bilateral Bispectral Index (BIS) StudyCompletedNCT01187420
• Remote Ischemic Preconditioning in Subarachnoid HemorrhageCompletedNCT01158508Phase 1
• Sildenafil for Prevention of Cerebral VasospasmWithdrawnNCT01091870Phase 2
• Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid HemorrhageCompletedNCT00962546
• Clazosentan in Aneurysmal Subarachnoid HemorrhageTerminatedNCT00940095Phase 3
• Lycopene Following Aneurysmal Subarachnoid HaemorrhageStatus unknownNCT00905931Phase 2
• Safety Study of Sildenafil in Treatment of Cerebral Aneurysm VasospasmWithdrawnNCT00871065Phase 2
• Eicosapentaenoic Acid Cerebral Vasospasm Therapy StudyCompletedNCT00839449Phase 4
• The Factors Cause Vasospasm After Aneurysmal Subarachnoid HemorrhageStatus unknownNCT00745758
• Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)CompletedNCT00692744
• Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAHTerminatedNCT00582868
• Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)CompletedNCT00111085Phase 2

← Vasospasm, Intracranial overview